Trailing-twelve-month (TTM) net income is $8.97 Billion with a year-over-year change of +15.65%. Net income represents the company's bottom line profit after all expenses, taxes, and interest.
Reported quarterly net income; no daily interpolation. Q2 FY2026 (2026-06-30): $2.37B.
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:03.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.
$8.97B
$8.97 Billion
+15.65%
vs. $7.76B a year ago (TTM)
+96.55%
5 Year compound annual growth rate
1 Year
+15.65%
3 Year
(3.30%)
5 Year
+96.55%
10 Year
(2.82%)
15 Year
(2.82%)
20 Year
(3.18%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Net Income | YoY Change | % Change |
|---|---|---|---|
| 2025 | $8.70B | +$2.15B | +32.76% |
| 2024 | $6.56B | ($2.93B) | (30.86%) |
| 2023 | $9.48B | +$9.15B | +2722.02% |
| 2022 | $336.00M | +$6.67B | N/A |
| 2021 | ($6.34B) | ($12.04B) | (211.10%) |
| 2020 |
TTM Growth
+15.65%
3-Year CAGR
(3.30%)
5-Year CAGR
+96.55%
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-09T20:00:03.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.
| $5.70B |
| +$10.68B |
| N/A |
| 2019 | ($4.98B) | +$17.38B | N/A |
| 2018 | ($22.36B) | ($13.87B) | N/A |
| 2017 | ($8.48B) | ($15.98B) | (213.12%) |
| 2016 | $7.50B | +$13.63B | N/A |
